InvestorsHub Logo

ignatiusrielly35

10/06/17 8:52 AM

#37344 RE: James salmon #37330

Nice, James. The cost of NEO and other personalized treatments also implies that there is room in the market for the "base" treatments such as AXAL, PSA, HOT, etc., even if NEO succeeds. Especially in the large markets like China and India.

huskercatman123

10/06/17 9:38 AM

#37348 RE: James salmon #37330

Thanks James. Seems to be talking mostly about the very expensive CAR-T treatments. Glad that our vaccine is low cost and thus far has had a great safety profile. If Efficacy ends up being equal; one would speculate that low cost and safety will win out in the end.

Simple Steve

10/06/17 9:45 AM

#37349 RE: James salmon #37330

Interesting and heart-warming story. There is no price on life. If it's your kid you sell your house and everything you own to save him/her. I would. Hopefully immunotherapy will move quickly to save innocent kids and people. That's one reason I'm wanting ADXS to move quickly. I noticed the video named other companies but unfortunately ADXS was not among them. That's how far under the radar we are.

Donjayouworry

10/06/17 12:44 PM

#37383 RE: James salmon #37330

Nice. Thanks James.

CATTDOGG12347

10/06/17 4:26 PM

#37412 RE: James salmon #37330

Great video!